# Broadcom timeline

entity: /record/broadcom.md  
id: ent_broadcom  


## undated

- undated | ticker | AVGO | valid | [clm_24D10FD883F5](/claim/clm_24D10FD883F5.md)
- undated | sic_industry | Semiconductors & Related Devices (3674) | valid | [clm_997AB4956731](/claim/clm_997AB4956731.md)
- undated | fiscal_year_end | 11-01 | valid | [clm_B85CB24019F5](/claim/clm_B85CB24019F5.md)
- undated | cik | 0001730168 | valid | [clm_D780C2C3DC0A](/claim/clm_D780C2C3DC0A.md)
- undated to 2018-02-06 | registrant_name | Broadcom Inc. | superseded | [clm_EE9DF5D48FAB](/claim/clm_EE9DF5D48FAB.md)
- undated | legal_form | public company | unverified | [clm_17DA47D50F9E](/claim/clm_17DA47D50F9E.md)
- undated | headquarters | Palo Alto | valid | [clm_1968825776FC](/claim/clm_1968825776FC.md)
- undated | website | https://www.broadcom.com/ | unverified | [clm_5345A8AE174D](/claim/clm_5345A8AE174D.md)

## 2006

- 2006-01-01 | board_member | Tan Hock Eng | valid | [clm_5864B939986B](/claim/clm_5864B939986B.md)
- 2006-03-01 | ceo | Tan Hock Eng | valid | [clm_9C2487174197](/claim/clm_9C2487174197.md)

## 2009

- 2009-01-01 | listed_on | Nasdaq | valid | [clm_841460812E77](/claim/clm_841460812E77.md)

## 2011

- 2011-07-19 | x_username | Broadcom | unverified | [clm_7ED821D446C3](/claim/clm_7ED821D446C3.md)

## 2015

- 2015-11-01 to 2016-10-30 | cash_and_equivalents | 1,822,000,000 United States dollar | superseded | [clm_3BFC55F36D11](/claim/clm_3BFC55F36D11.md)
- 2015-11-02 to 2016-10-30 | operating_income | -409,000,000 United States dollar | superseded | [clm_72A309AA856C](/claim/clm_72A309AA856C.md)
- 2015-11-02 to 2016-10-30 | net_income | -1,739,000,000 United States dollar | superseded | [clm_84021DD20E74](/claim/clm_84021DD20E74.md)
- 2015-11-02 to 2016-10-30 | revenue | 13,240,000,000 United States dollar | superseded | [clm_B7B575188057](/claim/clm_B7B575188057.md)

## 2016

- 2016-01-01 | board_member | Henry Samueli | valid | [clm_0A446546B1EE](/claim/clm_0A446546B1EE.md)
- 2016-01-01 | board_member | Low Check Kian | valid | [clm_9FD752215A4E](/claim/clm_9FD752215A4E.md)
- 2016-01-01 | board_member | Eddy Hartenstein | valid | [clm_B79686DBC840](/claim/clm_B79686DBC840.md)
- 2016-10-30 to 2016-10-31 | revenue | 13,240,000,000 United States dollar | superseded | [clm_1F40E72CB94C](/claim/clm_1F40E72CB94C.md)
- 2016-10-30 to 2016-10-31 | net_income | -1,739,000,000 United States dollar | superseded | [clm_5A20AFD367A5](/claim/clm_5A20AFD367A5.md)
- 2016-10-30 to 2017-04-30 | cash_and_equivalents | 3,097,000,000 United States dollar | superseded | [clm_7871037F1D12](/claim/clm_7871037F1D12.md)
- 2016-10-30 to 2016-10-31 | operating_income | -409,000,000 United States dollar | superseded | [clm_85E7304CBAAB](/claim/clm_85E7304CBAAB.md)
- 2016-10-30 to 2017-10-29 | research_and_development | 2,674,000,000 United States dollar | superseded | [clm_B06FE8B8B0F1](/claim/clm_B06FE8B8B0F1.md)
- 2016-10-31 to 2017-10-29 | operating_income | 2,383,000,000 United States dollar | superseded | [clm_9FCF8628C5F6](/claim/clm_9FCF8628C5F6.md)
- 2016-10-31 to 2017-10-29 | net_income | 1,692,000,000 United States dollar | superseded | [clm_B1968B779868](/claim/clm_B1968B779868.md)
- 2016-10-31 to 2017-10-29 | revenue | 17,636,000,000 United States dollar | superseded | [clm_CA074CE23018](/claim/clm_CA074CE23018.md)

## 2017

- 2017-01-01 | board_member | Gayla J. Delly | valid | [clm_077D8A1F9A8E](/claim/clm_077D8A1F9A8E.md)
- 2017-04-30 to 2017-07-30 | quarterly_net_income | 440,000,000 United States dollar | superseded | [clm_349A94E19AFE](/claim/clm_349A94E19AFE.md)
- 2017-04-30 to 2017-07-30 | quarterly_research_and_development | 829,000,000 United States dollar | superseded | [clm_4AB4CDC44CD5](/claim/clm_4AB4CDC44CD5.md)
- 2017-04-30 to 2017-07-30 | quarterly_operating_income | 474,000,000 United States dollar | superseded | [clm_65736A1BB2E6](/claim/clm_65736A1BB2E6.md)
- 2017-04-30 to 2017-07-30 | quarterly_revenue | 4,190,000,000 United States dollar | superseded | [clm_F3FFC2DC3BA1](/claim/clm_F3FFC2DC3BA1.md)
- 2017-04-30 to 2017-07-30 | cash_and_equivalents | 4,254,000,000 United States dollar | superseded | [clm_FB1EC8E6673B](/claim/clm_FB1EC8E6673B.md)
- 2017-07-30 to 2018-02-04 | quarterly_revenue | 4,463,000,000 United States dollar | superseded | [clm_34257C6B0858](/claim/clm_34257C6B0858.md)
- 2017-07-30 to 2018-02-04 | quarterly_operating_income | 648,000,000 United States dollar | superseded | [clm_5C54BD035150](/claim/clm_5C54BD035150.md)
- 2017-07-30 to 2017-10-29 | cash_and_equivalents | 5,249,000,000 United States dollar | superseded | [clm_81D8F14D6884](/claim/clm_81D8F14D6884.md)
- 2017-07-30 to 2018-02-04 | quarterly_net_income | 481,000,000 United States dollar | superseded | [clm_955FA1913DBD](/claim/clm_955FA1913DBD.md)
- 2017-07-30 to 2018-02-04 | quarterly_research_and_development | 827,000,000 United States dollar | superseded | [clm_C954F865ABFE](/claim/clm_C954F865ABFE.md)
- 2017-10-29 to 2018-02-04 | cash_and_equivalents | 11,204,000,000 United States dollar | superseded | [clm_1AEFE433D8FD](/claim/clm_1AEFE433D8FD.md)
- 2017-10-29 to 2017-10-30 | operating_income | 2,383,000,000 United States dollar | superseded | [clm_1BC2D02DD643](/claim/clm_1BC2D02DD643.md)
- 2017-10-29 to 2018-05-06 | total_equity | 20,285,000,000 United States dollar | superseded | [clm_26F422FF803A](/claim/clm_26F422FF803A.md)
- 2017-10-29 to 2017-10-30 | revenue | 17,636,000,000 United States dollar | superseded | [clm_2FAAF0F393DC](/claim/clm_2FAAF0F393DC.md)
- 2017-10-29 to 2018-11-04 | research_and_development | 3,292,000,000 United States dollar | superseded | [clm_78BBEF575531](/claim/clm_78BBEF575531.md)
- 2017-10-29 to 2018-05-06 | total_assets | 54,418,000,000 United States dollar | superseded | [clm_B649F1C1C9C5](/claim/clm_B649F1C1C9C5.md)
- 2017-10-29 to 2017-10-30 | net_income | 1,692,000,000 United States dollar | superseded | [clm_E175C883F545](/claim/clm_E175C883F545.md)
- 2017-10-30 to 2018-11-04 | revenue | 20,848,000,000 United States dollar | superseded | [clm_0BE4CDC22114](/claim/clm_0BE4CDC22114.md)
- 2017-10-30 to 2018-11-04 | operating_income | 5,135,000,000 United States dollar | superseded | [clm_994D218ADB57](/claim/clm_994D218ADB57.md)
- 2017-10-30 to 2018-11-04 | net_income | 12,259,000,000 United States dollar | superseded | [clm_9A37DF0E71B3](/claim/clm_9A37DF0E71B3.md)

## 2018

- 2018-02-04 to 2018-05-06 | cash_and_equivalents | 7,076,000,000 United States dollar | superseded | [clm_0186EB008B7C](/claim/clm_0186EB008B7C.md)
- 2018-02-04 to 2018-05-06 | quarterly_research_and_development | 925,000,000 United States dollar | superseded | [clm_5C057FEDCBBC](/claim/clm_5C057FEDCBBC.md)
- 2018-02-04 to 2018-05-06 | quarterly_revenue | 5,327,000,000 United States dollar | superseded | [clm_7679C7A6633E](/claim/clm_7679C7A6633E.md)
- 2018-02-04 to 2018-05-06 | quarterly_operating_income | 943,000,000 United States dollar | superseded | [clm_A5C2916AA3B6](/claim/clm_A5C2916AA3B6.md)
- 2018-02-04 to 2018-05-06 | quarterly_net_income | 6,230,000,000 United States dollar | superseded | [clm_C6D40CFAFFA5](/claim/clm_C6D40CFAFFA5.md)
- 2018-02-06 to 2018-03-09 | registrant_name | Broadcom Ltd | superseded | [clm_B485E81EEFE3](/claim/clm_B485E81EEFE3.md)
- 2018-05-06 to 2018-08-05 | quarterly_research_and_development | 936,000,000 United States dollar | superseded | [clm_0720E1486F6C](/claim/clm_0720E1486F6C.md)
- 2018-05-06 to 2018-08-05 | quarterly_operating_income | 1,201,000,000 United States dollar | superseded | [clm_1C9FA55EF2E9](/claim/clm_1C9FA55EF2E9.md)
- 2018-05-06 to 2018-08-05 | total_assets | 54,936,000,000 United States dollar | superseded | [clm_1FCC0E10BE9D](/claim/clm_1FCC0E10BE9D.md)
- 2018-05-06 to 2018-08-05 | quarterly_revenue | 5,014,000,000 United States dollar | superseded | [clm_39E9624571C3](/claim/clm_39E9624571C3.md)
- 2018-05-06 to 2018-08-05 | quarterly_net_income | 3,718,000,000 United States dollar | superseded | [clm_51296D4467B7](/claim/clm_51296D4467B7.md)
- 2018-05-06 to 2018-08-05 | cash_and_equivalents | 8,187,000,000 United States dollar | superseded | [clm_87B264DABB1C](/claim/clm_87B264DABB1C.md)
- 2018-05-06 to 2018-08-05 | total_equity | 32,067,000,000 United States dollar | superseded | [clm_A7B105B25C86](/claim/clm_A7B105B25C86.md)
- 2018-06-01 to 2018-08-31 | shares_outstanding | 431,680,880 shares | superseded | [clm_C854365226AF](/claim/clm_C854365226AF.md)
- 2018-08-05 to 2018-11-04 | total_assets | 50,372,000,000 United States dollar | superseded | [clm_26D67E7C894B](/claim/clm_26D67E7C894B.md)
- 2018-08-05 to 2018-11-04 | cash_and_equivalents | 4,136,000,000 United States dollar | superseded | [clm_2B3BF65B74DE](/claim/clm_2B3BF65B74DE.md)
- 2018-08-05 to 2018-11-04 | total_equity | 27,452,000,000 United States dollar | superseded | [clm_4A5263194DE0](/claim/clm_4A5263194DE0.md)
- 2018-08-05 to 2019-02-03 | quarterly_operating_income | 1,339,000,000 United States dollar | superseded | [clm_5EFD99328369](/claim/clm_5EFD99328369.md)
- 2018-08-05 to 2019-02-03 | quarterly_research_and_development | 959,000,000 United States dollar | superseded | [clm_7AFFE6DE3D02](/claim/clm_7AFFE6DE3D02.md)
- 2018-08-05 to 2019-02-03 | quarterly_revenue | 5,063,000,000 United States dollar | superseded | [clm_8828015255C3](/claim/clm_8828015255C3.md)
- 2018-08-05 to 2019-02-03 | quarterly_net_income | 1,196,000,000 United States dollar | superseded | [clm_A9849948D81F](/claim/clm_A9849948D81F.md)
- 2018-08-31 to 2018-11-30 | shares_outstanding | 413,446,755 shares | superseded | [clm_A827F76BAC4A](/claim/clm_A827F76BAC4A.md)
- 2018-11-04 to 2019-02-03 | cash_and_equivalents | 4,292,000,000 United States dollar | superseded | [clm_33E6112E0CD3](/claim/clm_33E6112E0CD3.md)
- 2018-11-04 to 2019-02-03 | total_assets | 50,124,000,000 United States dollar | superseded | [clm_6571BA9AA7EF](/claim/clm_6571BA9AA7EF.md)
- 2018-11-04 to 2018-11-05 | revenue | 20,848,000,000 United States dollar | superseded | [clm_6A1F9CC352E0](/claim/clm_6A1F9CC352E0.md)
- 2018-11-04 to 2018-11-05 | operating_income | 5,135,000,000 United States dollar | superseded | [clm_7110FC866B29](/claim/clm_7110FC866B29.md)
- 2018-11-04 to 2019-02-03 | total_equity | 26,657,000,000 United States dollar | superseded | [clm_73DA27090EF2](/claim/clm_73DA27090EF2.md)
- 2018-11-04 to 2018-11-05 | net_income | 12,259,000,000 United States dollar | superseded | [clm_8545315287F0](/claim/clm_8545315287F0.md)
- 2018-11-04 to 2019-11-03 | research_and_development | 3,768,000,000 United States dollar | superseded | [clm_F74B0AB502C4](/claim/clm_F74B0AB502C4.md)
- 2018-11-05 to 2019-11-03 | operating_income | 3,444,000,000 United States dollar | superseded | [clm_30462F9FF39A](/claim/clm_30462F9FF39A.md)
- 2018-11-05 to 2019-11-03 | net_income | 2,695,000,000 United States dollar | superseded | [clm_423A278D2C4B](/claim/clm_423A278D2C4B.md)
- 2018-11-05 to 2019-11-03 | revenue | 22,597,000,000 United States dollar | superseded | [clm_8F9507355384](/claim/clm_8F9507355384.md)
- 2018-11-30 to 2019-03-01 | shares_outstanding | 407,270,901 shares | superseded | [clm_0E3D33B97907](/claim/clm_0E3D33B97907.md)
- 2018-12-05 | chair | Henry Samueli | valid | [clm_D9383FBBB349](/claim/clm_D9383FBBB349.md)

## 2019

- 2019-01-08 | board_member | Harry L. You | valid | [clm_077F30F65D72](/claim/clm_077F30F65D72.md)
- 2019-01-11 | board_member | Diane Bryant | valid | [clm_47A26F7825D4](/claim/clm_47A26F7825D4.md)
- 2019-02-03 to 2019-05-05 | quarterly_net_income | 471,000,000 United States dollar | superseded | [clm_0D87FEA585B2](/claim/clm_0D87FEA585B2.md)
- 2019-02-03 to 2019-05-05 | cash_and_equivalents | 5,093,000,000 United States dollar | superseded | [clm_3489E5C56E97](/claim/clm_3489E5C56E97.md)
- 2019-02-03 to 2019-05-05 | total_assets | 72,110,000,000 United States dollar | superseded | [clm_44AA101D8B85](/claim/clm_44AA101D8B85.md)
- 2019-02-03 to 2019-05-05 | total_equity | 23,224,000,000 United States dollar | superseded | [clm_51DAA6E5559D](/claim/clm_51DAA6E5559D.md)
- 2019-02-03 to 2019-05-05 | quarterly_research_and_development | 1,133,000,000 United States dollar | superseded | [clm_BA23CBAD41D3](/claim/clm_BA23CBAD41D3.md)
- 2019-02-03 to 2019-05-05 | quarterly_revenue | 5,789,000,000 United States dollar | superseded | [clm_C48708A4F844](/claim/clm_C48708A4F844.md)
- 2019-02-03 to 2019-05-05 | quarterly_operating_income | 555,000,000 United States dollar | superseded | [clm_EC37CBC898E2](/claim/clm_EC37CBC898E2.md)
- 2019-03-01 to 2019-05-31 | shares_outstanding | 395,845,660 shares | superseded | [clm_B077BD99F73B](/claim/clm_B077BD99F73B.md)
- 2019-05-05 to 2019-08-04 | quarterly_revenue | 5,517,000,000 United States dollar | superseded | [clm_1582DD7F9649](/claim/clm_1582DD7F9649.md)
- 2019-05-05 to 2019-08-04 | quarterly_net_income | 691,000,000 United States dollar | superseded | [clm_1B564ED07C75](/claim/clm_1B564ED07C75.md)
- 2019-05-05 to 2019-08-04 | quarterly_research_and_development | 1,151,000,000 United States dollar | superseded | [clm_7452137F38E2](/claim/clm_7452137F38E2.md)
- 2019-05-05 to 2019-08-04 | total_assets | 70,916,000,000 United States dollar | superseded | [clm_C36390A44EE6](/claim/clm_C36390A44EE6.md)
- 2019-05-05 to 2019-08-04 | cash_and_equivalents | 5,328,000,000 United States dollar | superseded | [clm_DACB10F1E5F2](/claim/clm_DACB10F1E5F2.md)
- 2019-05-05 to 2019-08-04 | total_equity | 22,172,000,000 United States dollar | superseded | [clm_DCDC3EE28F18](/claim/clm_DCDC3EE28F18.md)
- 2019-05-05 to 2019-08-04 | quarterly_operating_income | 970,000,000 United States dollar | superseded | [clm_FF9A1D00E279](/claim/clm_FF9A1D00E279.md)
- 2019-05-31 to 2019-08-30 | shares_outstanding | 398,073,576 shares | superseded | [clm_0789B5F133AC](/claim/clm_0789B5F133AC.md)
- 2019-06-11 | board_member | Justine F. Page | valid | [clm_AF3E78A63201](/claim/clm_AF3E78A63201.md)
- 2019-08-04 to 2020-02-02 | quarterly_operating_income | 865,000,000 United States dollar | superseded | [clm_11A6046EEC6B](/claim/clm_11A6046EEC6B.md)
- 2019-08-04 to 2019-11-03 | cash_and_equivalents | 5,462,000,000 United States dollar | superseded | [clm_36A33CCAECD9](/claim/clm_36A33CCAECD9.md)
- 2019-08-04 to 2019-11-03 | total_assets | 69,767,000,000 United States dollar | superseded | [clm_7E30B2BF80D5](/claim/clm_7E30B2BF80D5.md)
- 2019-08-04 to 2019-11-03 | total_equity | 21,503,000,000 United States dollar | superseded | [clm_9BD8E64E3F25](/claim/clm_9BD8E64E3F25.md)
- 2019-08-04 | quarterly_net_income | 715,000,000 United States dollar | valid | [clm_B03A4BA6730C](/claim/clm_B03A4BA6730C.md)
- 2019-08-04 to 2020-02-02 | quarterly_revenue | 5,515,000,000 United States dollar | superseded | [clm_D1834A2E017C](/claim/clm_D1834A2E017C.md)
- 2019-08-04 to 2020-02-02 | quarterly_research_and_development | 1,235,000,000 United States dollar | superseded | [clm_FC5A4BFB12AE](/claim/clm_FC5A4BFB12AE.md)
- 2019-08-30 to 2019-11-29 | shares_outstanding | 396,670,773 shares | superseded | [clm_A8BBCFE3DFAD](/claim/clm_A8BBCFE3DFAD.md)
- 2019-11-03 to 2019-11-04 | operating_income | 3,444,000,000 United States dollar | superseded | [clm_0AB27DB8567A](/claim/clm_0AB27DB8567A.md)
- 2019-11-03 to 2021-10-31 | total_equity | 24,941,000,000 United States dollar | superseded | [clm_1982E80128F3](/claim/clm_1982E80128F3.md)
- 2019-11-03 to 2020-02-02 | cash_and_equivalents | 5,055,000,000 United States dollar | superseded | [clm_46A255282EBE](/claim/clm_46A255282EBE.md)
- 2019-11-03 to 2020-02-02 | total_assets | 67,493,000,000 United States dollar | superseded | [clm_71F94C4301FC](/claim/clm_71F94C4301FC.md)
- 2019-11-03 to 2020-11-01 | research_and_development | 4,696,000,000 United States dollar | superseded | [clm_8C4DEC4C25C3](/claim/clm_8C4DEC4C25C3.md)
- 2019-11-03 to 2019-11-04 | revenue | 22,597,000,000 United States dollar | superseded | [clm_ABC5A5078647](/claim/clm_ABC5A5078647.md)
- 2019-11-04 to 2020-11-01 | revenue | 23,888,000,000 United States dollar | superseded | [clm_05002EC06C6C](/claim/clm_05002EC06C6C.md)
- 2019-11-04 to 2020-11-01 | operating_income | 4,014,000,000 United States dollar | superseded | [clm_E45C3A470BE3](/claim/clm_E45C3A470BE3.md)
- 2019-11-29 to 2020-02-28 | shares_outstanding | 397,792,289 shares | superseded | [clm_A7F2D341DB1F](/claim/clm_A7F2D341DB1F.md)

## 2020

- 2020-02-02 to 2020-05-03 | cash_and_equivalents | 6,444,000,000 United States dollar | superseded | [clm_34EC973878E5](/claim/clm_34EC973878E5.md)
- 2020-02-02 to 2020-05-03 | total_assets | 81,006,000,000 United States dollar | superseded | [clm_89D18CD2FC7C](/claim/clm_89D18CD2FC7C.md)
- 2020-02-02 to 2020-05-03 | quarterly_research_and_development | 1,289,000,000 United States dollar | superseded | [clm_9660CB879091](/claim/clm_9660CB879091.md)
- 2020-02-02 to 2020-05-03 | quarterly_operating_income | 714,000,000 United States dollar | superseded | [clm_D3A86E26517E](/claim/clm_D3A86E26517E.md)
- 2020-02-02 to 2020-05-03 | quarterly_revenue | 5,858,000,000 United States dollar | superseded | [clm_FC789367A1A6](/claim/clm_FC789367A1A6.md)
- 2020-02-28 to 2020-05-29 | shares_outstanding | 399,791,345 shares | superseded | [clm_6885AEE9128B](/claim/clm_6885AEE9128B.md)
- 2020-05-03 to 2020-08-02 | quarterly_research_and_development | 1,269,000,000 United States dollar | superseded | [clm_04AE17B9C316](/claim/clm_04AE17B9C316.md)
- 2020-05-03 to 2020-08-02 | total_assets | 81,548,000,000 United States dollar | superseded | [clm_0CD10B667B08](/claim/clm_0CD10B667B08.md)
- 2020-05-03 to 2020-08-02 | quarterly_revenue | 5,742,000,000 United States dollar | superseded | [clm_944E611ABA96](/claim/clm_944E611ABA96.md)
- 2020-05-03 to 2020-08-02 | cash_and_equivalents | 9,207,000,000 United States dollar | superseded | [clm_D5C14A22F106](/claim/clm_D5C14A22F106.md)
- 2020-05-03 to 2020-08-02 | quarterly_operating_income | 766,000,000 United States dollar | superseded | [clm_DDF89F5E9041](/claim/clm_DDF89F5E9041.md)
- 2020-05-29 to 2020-08-28 | shares_outstanding | 402,185,283 shares | superseded | [clm_68A955A9C1B1](/claim/clm_68A955A9C1B1.md)
- 2020-08-02 to 2020-11-01 | total_assets | 79,298,000,000 United States dollar | superseded | [clm_0BAE5BD1E949](/claim/clm_0BAE5BD1E949.md)
- 2020-08-02 to 2021-01-31 | quarterly_operating_income | 1,008,000,000 United States dollar | superseded | [clm_606A339C4F53](/claim/clm_606A339C4F53.md)
- 2020-08-02 to 2021-01-31 | quarterly_revenue | 5,821,000,000 United States dollar | superseded | [clm_82C5786666C2](/claim/clm_82C5786666C2.md)
- 2020-08-02 to 2021-01-31 | quarterly_research_and_development | 1,228,000,000 United States dollar | superseded | [clm_AB5E1DCA3E37](/claim/clm_AB5E1DCA3E37.md)
- 2020-08-02 to 2020-11-01 | cash_and_equivalents | 8,857,000,000 United States dollar | superseded | [clm_C1FA540DBD73](/claim/clm_C1FA540DBD73.md)
- 2020-08-28 to 2020-11-27 | shares_outstanding | 404,501,331 shares | superseded | [clm_95789057B223](/claim/clm_95789057B223.md)
- 2020-11-01 to 2021-01-31 | total_assets | 75,933,000,000 United States dollar | superseded | [clm_04A466653E31](/claim/clm_04A466653E31.md)
- 2020-11-01 to 2021-10-31 | operating_income | 4,014,000,000 United States dollar | superseded | [clm_1DD23A00B33D](/claim/clm_1DD23A00B33D.md)
- 2020-11-01 to 2021-10-31 | research_and_development | 4,968,000,000 United States dollar | superseded | [clm_3DF2CE68DDFD](/claim/clm_3DF2CE68DDFD.md)
- 2020-11-01 to 2021-10-31 | net_income | 2,960,000,000 United States dollar | superseded | [clm_97C493620675](/claim/clm_97C493620675.md)
- 2020-11-01 to 2021-10-31 | revenue | 23,888,000,000 United States dollar | superseded | [clm_9F62932762A5](/claim/clm_9F62932762A5.md)
- 2020-11-01 to 2021-01-31 | cash_and_equivalents | 7,618,000,000 United States dollar | superseded | [clm_BF12D48EF166](/claim/clm_BF12D48EF166.md)
- 2020-11-27 to 2021-02-26 | shares_outstanding | 406,713,118 shares | superseded | [clm_CC6A78F1D015](/claim/clm_CC6A78F1D015.md)

## 2021

- 2021-01-31 to 2021-05-02 | total_assets | 76,972,000,000 United States dollar | superseded | [clm_7B5EE7D273C3](/claim/clm_7B5EE7D273C3.md)
- 2021-01-31 to 2021-05-02 | quarterly_operating_income | 1,837,000,000 United States dollar | superseded | [clm_871E07EFF36D](/claim/clm_871E07EFF36D.md)
- 2021-01-31 to 2021-05-02 | quarterly_revenue | 6,655,000,000 United States dollar | superseded | [clm_8F701D28A1F4](/claim/clm_8F701D28A1F4.md)
- 2021-01-31 to 2021-05-02 | cash_and_equivalents | 9,552,000,000 United States dollar | superseded | [clm_BFC31A0C24B8](/claim/clm_BFC31A0C24B8.md)
- 2021-01-31 to 2021-05-02 | quarterly_research_and_development | 1,211,000,000 United States dollar | superseded | [clm_D5D97A83A179](/claim/clm_D5D97A83A179.md)
- 2021-02-26 to 2021-05-28 | shares_outstanding | 408,302,326 shares | superseded | [clm_D5AC1137B697](/claim/clm_D5AC1137B697.md)
- 2021-05-02 to 2021-08-01 | quarterly_revenue | 6,610,000,000 United States dollar | superseded | [clm_189A2D30D74D](/claim/clm_189A2D30D74D.md)
- 2021-05-02 to 2021-08-01 | quarterly_operating_income | 1,975,000,000 United States dollar | superseded | [clm_37EC08CC7686](/claim/clm_37EC08CC7686.md)
- 2021-05-02 to 2021-08-01 | quarterly_research_and_development | 1,238,000,000 United States dollar | superseded | [clm_4FDF41A7D657](/claim/clm_4FDF41A7D657.md)
- 2021-05-02 to 2021-08-01 | total_assets | 75,524,000,000 United States dollar | superseded | [clm_76D6A8CC87CB](/claim/clm_76D6A8CC87CB.md)
- 2021-05-02 to 2021-08-01 | cash_and_equivalents | 9,518,000,000 United States dollar | superseded | [clm_B3BDB15F50E8](/claim/clm_B3BDB15F50E8.md)
- 2021-05-28 to 2021-08-27 | shares_outstanding | 410,260,560 shares | superseded | [clm_462A1FAB8862](/claim/clm_462A1FAB8862.md)
- 2021-08-01 to 2021-10-31 | total_assets | 75,880,000,000 United States dollar | superseded | [clm_38480ABA7E4B](/claim/clm_38480ABA7E4B.md)
- 2021-08-01 to 2022-01-30 | quarterly_research_and_development | 1,205,000,000 United States dollar | superseded | [clm_449CA2712377](/claim/clm_449CA2712377.md)
- 2021-08-01 to 2022-01-30 | quarterly_revenue | 6,778,000,000 United States dollar | superseded | [clm_89266BC27D7C](/claim/clm_89266BC27D7C.md)
- 2021-08-01 to 2021-10-31 | cash_and_equivalents | 11,105,000,000 United States dollar | superseded | [clm_B6F9F8D46EDB](/claim/clm_B6F9F8D46EDB.md)
- 2021-08-01 to 2022-01-30 | quarterly_operating_income | 2,126,000,000 United States dollar | superseded | [clm_D22BF5C02D5E](/claim/clm_D22BF5C02D5E.md)
- 2021-08-27 to 2021-11-26 | shares_outstanding | 411,616,288 shares | superseded | [clm_541FC27DD1E3](/claim/clm_541FC27DD1E3.md)
- 2021-10-31 to 2023-10-29 | total_equity | 24,962,000,000 United States dollar | superseded | [clm_2817EF17C256](/claim/clm_2817EF17C256.md)
- 2021-10-31 to 2022-01-30 | total_assets | 75,570,000,000 United States dollar | superseded | [clm_3C4E341DE76B](/claim/clm_3C4E341DE76B.md)
- 2021-10-31 to 2021-11-01 | revenue | 27,450,000,000 United States dollar | superseded | [clm_563E3E56F0EE](/claim/clm_563E3E56F0EE.md)
- 2021-10-31 to 2022-01-30 | cash_and_equivalents | 12,163,000,000 United States dollar | superseded | [clm_7A756C96C638](/claim/clm_7A756C96C638.md)
- 2021-10-31 to 2023-10-29 | employees | 20,000 | superseded | [clm_8054276578A5](/claim/clm_8054276578A5.md)
- 2021-10-31 to 2021-11-01 | operating_income | 8,519,000,000 United States dollar | superseded | [clm_B4A5BB4991CE](/claim/clm_B4A5BB4991CE.md)
- 2021-10-31 to 2022-10-30 | net_income | 6,736,000,000 United States dollar | superseded | [clm_F567D98C64FE](/claim/clm_F567D98C64FE.md)
- 2021-10-31 to 2022-10-30 | research_and_development | 4,854,000,000 United States dollar | superseded | [clm_FCED77A07405](/claim/clm_FCED77A07405.md)
- 2021-11-01 to 2022-10-30 | operating_income | 14,225,000,000 United States dollar | superseded | [clm_462EBB7C94AA](/claim/clm_462EBB7C94AA.md)
- 2021-11-01 to 2022-10-30 | revenue | 33,203,000,000 United States dollar | superseded | [clm_B5787295CD9F](/claim/clm_B5787295CD9F.md)
- 2021-11-26 to 2022-02-25 | shares_outstanding | 412,873,968 shares | superseded | [clm_12221BA7F79B](/claim/clm_12221BA7F79B.md)

## 2022

- 2022-01-30 to 2022-05-01 | quarterly_revenue | 7,706,000,000 United States dollar | superseded | [clm_0F0DE94A9B1A](/claim/clm_0F0DE94A9B1A.md)
- 2022-01-30 to 2022-05-01 | total_assets | 73,224,000,000 United States dollar | superseded | [clm_48A2EB158D41](/claim/clm_48A2EB158D41.md)
- 2022-01-30 to 2022-05-01 | quarterly_research_and_development | 1,206,000,000 United States dollar | superseded | [clm_64E8F720A25F](/claim/clm_64E8F720A25F.md)
- 2022-01-30 to 2022-05-01 | quarterly_operating_income | 3,108,000,000 United States dollar | superseded | [clm_C20396896691](/claim/clm_C20396896691.md)
- 2022-01-30 to 2022-05-01 | cash_and_equivalents | 10,219,000,000 United States dollar | superseded | [clm_D57F9F5FAD2B](/claim/clm_D57F9F5FAD2B.md)
- 2022-02-25 to 2022-05-27 | shares_outstanding | 408,281,170 shares | superseded | [clm_FF71EC7E6C67](/claim/clm_FF71EC7E6C67.md)
- 2022-05-01 to 2022-07-31 | quarterly_revenue | 8,103,000,000 United States dollar | superseded | [clm_26C230A0321B](/claim/clm_26C230A0321B.md)
- 2022-05-01 to 2022-07-31 | quarterly_research_and_development | 1,261,000,000 United States dollar | superseded | [clm_62673755D092](/claim/clm_62673755D092.md)
- 2022-05-01 to 2022-07-31 | total_assets | 71,719,000,000 United States dollar | superseded | [clm_C990F2BC9071](/claim/clm_C990F2BC9071.md)
- 2022-05-01 to 2022-07-31 | quarterly_operating_income | 3,394,000,000 United States dollar | superseded | [clm_CE26AF4AF532](/claim/clm_CE26AF4AF532.md)
- 2022-05-01 to 2022-07-31 | cash_and_equivalents | 9,005,000,000 United States dollar | superseded | [clm_E7DB3DE79D7A](/claim/clm_E7DB3DE79D7A.md)
- 2022-05-27 to 2022-08-26 | shares_outstanding | 403,817,700 shares | superseded | [clm_6DD2E6A94584](/claim/clm_6DD2E6A94584.md)
- 2022-07-31 to 2022-10-30 | cash_and_equivalents | 9,977,000,000 United States dollar | superseded | [clm_57C398B55B06](/claim/clm_57C398B55B06.md)
- 2022-07-31 to 2022-10-30 | total_assets | 71,326,000,000 United States dollar | superseded | [clm_59FF383120D2](/claim/clm_59FF383120D2.md)
- 2022-07-31 to 2023-01-29 | quarterly_research_and_development | 1,255,000,000 United States dollar | superseded | [clm_6C8F0A488368](/claim/clm_6C8F0A488368.md)
- 2022-07-31 to 2023-01-29 | quarterly_revenue | 8,464,000,000 United States dollar | superseded | [clm_B1EFC1A33A61](/claim/clm_B1EFC1A33A61.md)
- 2022-07-31 to 2023-01-29 | quarterly_operating_income | 3,737,000,000 United States dollar | superseded | [clm_EDFCA8A08B9C](/claim/clm_EDFCA8A08B9C.md)
- 2022-08-26 to 2022-11-25 | shares_outstanding | 405,001,456 shares | superseded | [clm_B62723F330D4](/claim/clm_B62723F330D4.md)
- 2022-10-30 to 2023-01-29 | cash_and_equivalents | 12,416,000,000 United States dollar | superseded | [clm_0B0777288581](/claim/clm_0B0777288581.md)
- 2022-10-30 to 2023-10-29 | operating_income | 14,225,000,000 United States dollar | superseded | [clm_1B0D3E91AE16](/claim/clm_1B0D3E91AE16.md)
- 2022-10-30 to 2023-10-29 | research_and_development | 4,919,000,000 United States dollar | superseded | [clm_D7B24A60C3E1](/claim/clm_D7B24A60C3E1.md)
- 2022-10-30 to 2023-10-29 | net_income | 11,495,000,000 United States dollar | superseded | [clm_E0EC91DF5007](/claim/clm_E0EC91DF5007.md)
- 2022-10-30 to 2023-10-29 | revenue | 33,203,000,000 United States dollar | superseded | [clm_FB0F1849DCC7](/claim/clm_FB0F1849DCC7.md)
- 2022-10-30 to 2023-01-29 | total_assets | 73,249,000,000 United States dollar | superseded | [clm_FD5795294E36](/claim/clm_FD5795294E36.md)
- 2022-11-25 to 2023-02-24 | shares_outstanding | 417,886,140 shares | superseded | [clm_80FC7FC8787F](/claim/clm_80FC7FC8787F.md)

## 2023

- 2023-01-29 to 2023-04-30 | quarterly_operating_income | 4,103,000,000 United States dollar | superseded | [clm_35F0F456752D](/claim/clm_35F0F456752D.md)
- 2023-01-29 to 2023-04-30 | quarterly_research_and_development | 1,195,000,000 United States dollar | superseded | [clm_4BE0F1112B9E](/claim/clm_4BE0F1112B9E.md)
- 2023-01-29 to 2023-04-30 | total_assets | 72,976,000,000 United States dollar | superseded | [clm_69C7BA18A031](/claim/clm_69C7BA18A031.md)
- 2023-01-29 to 2023-04-30 | cash_and_equivalents | 12,647,000,000 United States dollar | superseded | [clm_E8116B01C302](/claim/clm_E8116B01C302.md)
- 2023-01-29 to 2023-04-30 | quarterly_revenue | 8,915,000,000 United States dollar | superseded | [clm_F05BDA826C96](/claim/clm_F05BDA826C96.md)
- 2023-02-24 to 2023-05-26 | shares_outstanding | 416,923,664 shares | superseded | [clm_797A38BA51D6](/claim/clm_797A38BA51D6.md)
- 2023-04-30 to 2023-07-30 | total_assets | 71,667,000,000 United States dollar | superseded | [clm_26F1E7F784A3](/claim/clm_26F1E7F784A3.md)
- 2023-04-30 to 2023-07-30 | quarterly_operating_income | 4,008,000,000 United States dollar | superseded | [clm_55336E7095F8](/claim/clm_55336E7095F8.md)
- 2023-04-30 to 2023-07-30 | quarterly_research_and_development | 1,312,000,000 United States dollar | superseded | [clm_8CE75727233B](/claim/clm_8CE75727233B.md)
- 2023-04-30 to 2023-07-30 | quarterly_revenue | 8,733,000,000 United States dollar | superseded | [clm_9015F9A615DC](/claim/clm_9015F9A615DC.md)
- 2023-04-30 to 2023-07-30 | cash_and_equivalents | 11,553,000,000 United States dollar | superseded | [clm_D9E7D70CC2DE](/claim/clm_D9E7D70CC2DE.md)
- 2023-05-26 to 2023-08-25 | shares_outstanding | 412,685,405 shares | superseded | [clm_0AEFF23B3370](/claim/clm_0AEFF23B3370.md)
- 2023-07-30 to 2024-02-04 | quarterly_revenue | 8,876,000,000 United States dollar | superseded | [clm_18133AD87350](/claim/clm_18133AD87350.md)
- 2023-07-30 to 2023-10-29 | total_assets | 71,595,000,000 United States dollar | superseded | [clm_24F806F6CF82](/claim/clm_24F806F6CF82.md)
- 2023-07-30 to 2023-10-29 | cash_and_equivalents | 12,055,000,000 United States dollar | superseded | [clm_4B7FB7AA7623](/claim/clm_4B7FB7AA7623.md)
- 2023-07-30 to 2024-02-04 | quarterly_operating_income | 3,856,000,000 United States dollar | superseded | [clm_593388A5135C](/claim/clm_593388A5135C.md)
- 2023-07-30 to 2024-02-04 | quarterly_research_and_development | 1,358,000,000 United States dollar | superseded | [clm_6D2FF818F081](/claim/clm_6D2FF818F081.md)
- 2023-08-25 to 2023-11-24 | shares_outstanding | 412,735,504 shares | superseded | [clm_CDA5B59638DF](/claim/clm_CDA5B59638DF.md)
- 2023-10-29 to 2023-10-30 | revenue | 35,819,000,000 United States dollar | superseded | [clm_0E50E61EC854](/claim/clm_0E50E61EC854.md)
- 2023-10-29 | employees | 20,000 | valid | [clm_10416D16AA5D](/claim/clm_10416D16AA5D.md)
- 2023-10-29 | total_equity | 23,988,000,000 United States dollar | valid | [clm_69BDB3CFF67E](/claim/clm_69BDB3CFF67E.md)
- 2023-10-29 to 2024-02-04 | cash_and_equivalents | 14,189,000,000 United States dollar | superseded | [clm_847074E768EB](/claim/clm_847074E768EB.md)
- 2023-10-29 to 2023-10-30 | operating_income | 16,207,000,000 United States dollar | superseded | [clm_AEDB5A55B86E](/claim/clm_AEDB5A55B86E.md)
- 2023-10-29 to 2024-02-04 | total_assets | 72,861,000,000 United States dollar | superseded | [clm_B3394EB00FD7](/claim/clm_B3394EB00FD7.md)
- 2023-10-29 to 2024-11-03 | research_and_development | 5,253,000,000 United States dollar | superseded | [clm_ED482318724A](/claim/clm_ED482318724A.md)
- 2023-10-29 to 2023-10-30 | net_income | 14,082,000,000 United States dollar | superseded | [clm_F1A97C43D76F](/claim/clm_F1A97C43D76F.md)
- 2023-10-30 to 2024-11-03 | revenue | 51,574,000,000 United States dollar | superseded | [clm_47AF3721A163](/claim/clm_47AF3721A163.md)
- 2023-10-30 to 2024-11-03 | net_income | 5,895,000,000 United States dollar | superseded | [clm_63A1B7EB9288](/claim/clm_63A1B7EB9288.md)
- 2023-10-30 to 2024-11-03 | operating_income | 13,463,000,000 United States dollar | superseded | [clm_A26C5865F70F](/claim/clm_A26C5865F70F.md)
- 2023-11-24 to 2024-03-01 | shares_outstanding | 468,140,569 shares | superseded | [clm_8F90B0407E6C](/claim/clm_8F90B0407E6C.md)

## 2024

- 2024-02-04 to 2024-05-05 | cash_and_equivalents | 11,864,000,000 United States dollar | superseded | [clm_10D8862E5441](/claim/clm_10D8862E5441.md)
- 2024-02-04 to 2024-05-05 | quarterly_research_and_development | 2,308,000,000 United States dollar | superseded | [clm_207BA730466B](/claim/clm_207BA730466B.md)
- 2024-02-04 to 2024-05-05 | total_assets | 177,870,000,000 United States dollar | superseded | [clm_505B5A467D9B](/claim/clm_505B5A467D9B.md)
- 2024-02-04 to 2024-05-05 | quarterly_operating_income | 2,083,000,000 United States dollar | superseded | [clm_51BA035C4E2D](/claim/clm_51BA035C4E2D.md)
- 2024-02-04 to 2024-05-05 | quarterly_revenue | 11,961,000,000 United States dollar | superseded | [clm_6AB3EDDBB73A](/claim/clm_6AB3EDDBB73A.md)
- 2024-02-05 | board_member | Kenneth Y. Hao | valid | [clm_AE9A46AFCFFD](/claim/clm_AE9A46AFCFFD.md)
- 2024-03-01 to 2024-05-31 | shares_outstanding | 463,421,237 shares | superseded | [clm_62AE87E72A91](/claim/clm_62AE87E72A91.md)
- 2024-05-05 to 2024-08-04 | cash_and_equivalents | 9,809,000,000 United States dollar | superseded | [clm_1690BA97CEA3](/claim/clm_1690BA97CEA3.md)
- 2024-05-05 to 2024-08-04 | quarterly_revenue | 12,487,000,000 United States dollar | superseded | [clm_50DC9B84B2C0](/claim/clm_50DC9B84B2C0.md)
- 2024-05-05 to 2024-08-04 | total_assets | 175,211,000,000 United States dollar | superseded | [clm_5F77F85FC324](/claim/clm_5F77F85FC324.md)
- 2024-05-05 to 2024-08-04 | quarterly_operating_income | 2,965,000,000 United States dollar | superseded | [clm_976E5C3AD710](/claim/clm_976E5C3AD710.md)
- 2024-05-05 to 2024-08-04 | quarterly_research_and_development | 2,415,000,000 United States dollar | superseded | [clm_FB69DC21134D](/claim/clm_FB69DC21134D.md)
- 2024-05-31 to 2024-08-30 | shares_outstanding | 465,488,374 shares | superseded | [clm_66B0035C9B55](/claim/clm_66B0035C9B55.md)
- 2024-08-04 to 2024-11-03 | total_assets | 167,966,000,000 United States dollar | superseded | [clm_0DD8008F210F](/claim/clm_0DD8008F210F.md)
- 2024-08-04 to 2025-02-02 | quarterly_research_and_development | 2,353,000,000 United States dollar | superseded | [clm_2DE55A5CF7CD](/claim/clm_2DE55A5CF7CD.md)
- 2024-08-04 to 2025-02-02 | quarterly_revenue | 13,072,000,000 United States dollar | superseded | [clm_3BBD6D7BAE47](/claim/clm_3BBD6D7BAE47.md)
- 2024-08-04 to 2025-02-02 | quarterly_operating_income | 3,788,000,000 United States dollar | superseded | [clm_4752CE8A8A86](/claim/clm_4752CE8A8A86.md)
- 2024-08-04 to 2024-11-03 | cash_and_equivalents | 9,952,000,000 United States dollar | superseded | [clm_EF35D65D0FB5](/claim/clm_EF35D65D0FB5.md)
- 2024-08-30 to 2024-11-29 | shares_outstanding | 4,670,576,083 shares | superseded | [clm_D3A1D5F9476B](/claim/clm_D3A1D5F9476B.md)
- 2024-11-03 to 2025-11-02 | research_and_development | 9,310,000,000 United States dollar | superseded | [clm_4C199573936B](/claim/clm_4C199573936B.md)
- 2024-11-03 to 2025-02-02 | cash_and_equivalents | 9,348,000,000 United States dollar | superseded | [clm_5427FF548238](/claim/clm_5427FF548238.md)
- 2024-11-03 to 2024-11-04 | revenue | 51,574,000,000 United States dollar | superseded | [clm_5483CF78925C](/claim/clm_5483CF78925C.md)
- 2024-11-03 to 2025-02-02 | total_assets | 165,645,000,000 United States dollar | superseded | [clm_89886DB93A34](/claim/clm_89886DB93A34.md)
- 2024-11-03 to 2024-11-04 | operating_income | 13,463,000,000 United States dollar | superseded | [clm_8BEEA937EB15](/claim/clm_8BEEA937EB15.md)
- 2024-11-03 to 2024-11-04 | net_income | 5,895,000,000 United States dollar | superseded | [clm_F9CF9234100D](/claim/clm_F9CF9234100D.md)
- 2024-11-04 to 2025-11-02 | net_income | 23,126,000,000 United States dollar | superseded | [clm_08084C885FF1](/claim/clm_08084C885FF1.md)
- 2024-11-04 to 2025-11-02 | operating_income | 25,484,000,000 United States dollar | superseded | [clm_80E01701AD60](/claim/clm_80E01701AD60.md)
- 2024-11-04 to 2025-11-02 | revenue | 63,887,000,000 United States dollar | superseded | [clm_970F10F77D3F](/claim/clm_970F10F77D3F.md)
- 2024-11-29 to 2025-02-28 | shares_outstanding | 4,687,356,156 shares | superseded | [clm_90A9E9E76663](/claim/clm_90A9E9E76663.md)

## 2025

- 2025-02-02 to 2025-05-04 | quarterly_revenue | 14,916,000,000 United States dollar | superseded | [clm_0136D2BBE77A](/claim/clm_0136D2BBE77A.md)
- 2025-02-02 to 2025-05-04 | quarterly_research_and_development | 2,253,000,000 United States dollar | superseded | [clm_1921FDDDBCF7](/claim/clm_1921FDDDBCF7.md)
- 2025-02-02 to 2025-05-04 | quarterly_operating_income | 6,260,000,000 United States dollar | superseded | [clm_1B9ABD618E5A](/claim/clm_1B9ABD618E5A.md)
- 2025-02-02 to 2025-05-04 | cash_and_equivalents | 9,307,000,000 United States dollar | superseded | [clm_D13C8A871647](/claim/clm_D13C8A871647.md)
- 2025-02-02 to 2025-05-04 | total_assets | 165,358,000,000 United States dollar | superseded | [clm_FB9BDECAA36A](/claim/clm_FB9BDECAA36A.md)
- 2025-02-28 to 2025-05-30 | shares_outstanding | 4,701,948,717 shares | superseded | [clm_312635FB6D05](/claim/clm_312635FB6D05.md)
- 2025-05-04 to 2025-08-03 | quarterly_operating_income | 5,829,000,000 United States dollar | superseded | [clm_051A08D3E55C](/claim/clm_051A08D3E55C.md)
- 2025-05-04 to 2025-08-03 | quarterly_revenue | 15,004,000,000 United States dollar | superseded | [clm_3AAD1266EF87](/claim/clm_3AAD1266EF87.md)
- 2025-05-04 to 2025-08-03 | total_assets | 164,630,000,000 United States dollar | superseded | [clm_A1FC9C26551B](/claim/clm_A1FC9C26551B.md)
- 2025-05-04 to 2025-08-03 | cash_and_equivalents | 9,472,000,000 United States dollar | superseded | [clm_D66085001839](/claim/clm_D66085001839.md)
- 2025-05-04 to 2025-08-03 | quarterly_research_and_development | 2,693,000,000 United States dollar | superseded | [clm_F51EF7A5A27E](/claim/clm_F51EF7A5A27E.md)
- 2025-05-30 to 2025-08-29 | shares_outstanding | 4,703,470,979 shares | superseded | [clm_6583A6475651](/claim/clm_6583A6475651.md)
- 2025-08-03 to 2025-11-02 | cash_and_equivalents | 10,718,000,000 United States dollar | superseded | [clm_13DD4B135742](/claim/clm_13DD4B135742.md)
- 2025-08-03 to 2025-11-02 | total_assets | 165,621,000,000 United States dollar | superseded | [clm_46951625A109](/claim/clm_46951625A109.md)
- 2025-08-03 to 2026-02-01 | quarterly_operating_income | 5,887,000,000 United States dollar | superseded | [clm_729DFF84B284](/claim/clm_729DFF84B284.md)
- 2025-08-03 to 2026-02-01 | quarterly_revenue | 15,952,000,000 United States dollar | superseded | [clm_7AD3373297CA](/claim/clm_7AD3373297CA.md)
- 2025-08-03 to 2026-02-01 | quarterly_research_and_development | 3,050,000,000 United States dollar | superseded | [clm_A17E607EAED5](/claim/clm_A17E607EAED5.md)
- 2025-08-29 to 2025-11-28 | shares_outstanding | 4,722,365,022 shares | superseded | [clm_D4507D2604E6](/claim/clm_D4507D2604E6.md)
- 2025-11-02 to 2026-02-01 | cash_and_equivalents | 16,178,000,000 United States dollar | superseded | [clm_124631996EEC](/claim/clm_124631996EEC.md)
- 2025-11-02 | research_and_development | 10,977,000,000 United States dollar | valid | [clm_16DEB4E0C05E](/claim/clm_16DEB4E0C05E.md)
- 2025-11-02 | operating_income | 25,484,000,000 United States dollar | valid | [clm_99DA7E54D287](/claim/clm_99DA7E54D287.md)
- 2025-11-02 | revenue | 63,887,000,000 United States dollar | valid | [clm_9BDD67B6C467](/claim/clm_9BDD67B6C467.md)
- 2025-11-02 to 2026-02-01 | total_assets | 171,092,000,000 United States dollar | superseded | [clm_D5ADCC4074D3](/claim/clm_D5ADCC4074D3.md)
- 2025-11-28 to 2026-02-27 | shares_outstanding | 4,741,273,799 shares | superseded | [clm_8889C0053634](/claim/clm_8889C0053634.md)

## 2026

- 2026-02-01 to 2026-05-03 | cash_and_equivalents | 14,174,000,000 United States dollar | superseded | [clm_015547BA2206](/claim/clm_015547BA2206.md)
- 2026-02-01 to 2026-05-03 | quarterly_revenue | 19,311,000,000 United States dollar | superseded | [clm_0937C655EC53](/claim/clm_0937C655EC53.md)
- 2026-02-01 to 2026-05-03 | quarterly_research_and_development | 2,965,000,000 United States dollar | superseded | [clm_7A1E5BF18318](/claim/clm_7A1E5BF18318.md)
- 2026-02-01 to 2026-05-03 | quarterly_operating_income | 8,563,000,000 United States dollar | superseded | [clm_A110660F3D21](/claim/clm_A110660F3D21.md)
- 2026-02-01 to 2026-05-03 | total_assets | 169,903,000,000 United States dollar | superseded | [clm_C19AC1DE804B](/claim/clm_C19AC1DE804B.md)
- 2026-02-27 to 2026-05-29 | shares_outstanding | 4,734,668,184 shares | superseded | [clm_B461E6F7029A](/claim/clm_B461E6F7029A.md)
- 2026-05-03 to 2026-08-02 | quarterly_revenue | 22,187,000,000 United States dollar | superseded | [clm_393AD7FD38FE](/claim/clm_393AD7FD38FE.md)
- 2026-05-03 to 2026-08-02 | total_assets | 179,158,000,000 United States dollar | superseded | [clm_3DEB8C171B00](/claim/clm_3DEB8C171B00.md)
- 2026-05-03 to 2026-08-02 | quarterly_operating_income | 10,788,000,000 United States dollar | superseded | [clm_484AD955E2D7](/claim/clm_484AD955E2D7.md)
- 2026-05-03 to 2026-08-02 | quarterly_research_and_development | 2,995,000,000 United States dollar | superseded | [clm_C63DF4F22CA1](/claim/clm_C63DF4F22CA1.md)
- 2026-05-03 to 2026-08-02 | cash_and_equivalents | 19,628,000,000 United States dollar | superseded | [clm_DC4050AD392B](/claim/clm_DC4050AD392B.md)
- 2026-05-29 to 2026-08-28 | shares_outstanding | 4,757,580,198 shares | superseded | [clm_AAF9B19CD618](/claim/clm_AAF9B19CD618.md)
- 2026-06-12 | cfo | Amie Thuener | valid | [clm_ADD2D062DC2F](/claim/clm_ADD2D062DC2F.md)
- 2026-08-02 | quarterly_research_and_development | 2,895,000,000 United States dollar | valid | [clm_0AC1DF565996](/claim/clm_0AC1DF565996.md)
- 2026-08-02 | quarterly_revenue | 29,591,000,000 United States dollar | valid | [clm_1413FA01071B](/claim/clm_1413FA01071B.md)
- 2026-08-02 | total_assets | 188,148,000,000 United States dollar | valid | [clm_62287543FE3C](/claim/clm_62287543FE3C.md)
- 2026-08-02 | quarterly_operating_income | 15,955,000,000 United States dollar | valid | [clm_BFA869E4F08B](/claim/clm_BFA869E4F08B.md)
- 2026-08-02 | cash_and_equivalents | 23,975,000,000 United States dollar | valid | [clm_EEBFEC59CC94](/claim/clm_EEBFEC59CC94.md)
- 2026-08-28 | shares_outstanding | 4,773,629,865 shares | valid | [clm_E35BF91212F7](/claim/clm_E35BF91212F7.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.